Obesidad: un problema en la atención de Covid-19

Obesity: a problem in Covid-19 care

Actualmente el mundo atraviesa una de las peores crisis a nivel salud secundario a la infección por un nuevo coronavirus de alta transmisibilidad y mortalidad, que ha impactado múltiples aspectos. Se ha establecido de forma general que la severidad de la infección está asociada con edad avanzada y comorbilidades como hipertensión y diabetes. Por otro lado, la obesidad en este momento representa una de las mayores amenazas del sector salud, por su gran relación con morbimortalidad a nivel cardiometabólico, esto conlleva a un alto costo de la enfermedad. Este artículo busca alertar sobre lo que han llamado algunos expertos el “choque de dos pandemias”, esto dado al aumento de la prevalencia de obesidad a nivel mundial, donde  nuestro país no está exento, que podría relacionarse con un número mayor de personas vulnerables a la infección por COVID-19 y sus complicaciones respiratorias y de esta manera evitar desenlaces catastróficos.

1. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease. Circulation [Internet]. 2020;2019. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/32200663 doi: 10.1161/CIRCULATIONAHA.120.046941
2. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team [corresponding author Yanping Zhang]. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Wkly. 2020;2(8):113–22.
3. Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, Hansen BC, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Metab. 2006;290(6):E1253-61 doi: 10.1152/ajpendo.00572.2004
4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5
5. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62. doi: 10.1016/S0140-6736(20)30566-3
6. Centers for Disease Control and Prevention. People at High Risk For Flu Complications [Internet]. 2020. Disponible en: https://www.cdc.gov/flu/highrisk/index.htm
7. Louie JK, Acosta M, Winter K, Jean C, Gavali S, Schechter R, et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA - J Am Med Assoc. 2009;302(17):1896–902. doi: 10.1001/jama.2009.1583
8. Venkata C, Sampathkumar P, Afessa B. Hospitalized patients with 2009 H1N1 influenza infection: The mayo clinic experience. Mayo Clin Proc. 2010;85(9):798–805. doi: 10.4065/mcp.2010.0166
9. Thompson DL, Jungk J, Hancock E, Smelser C, Landen M, Nichols M, et al. Risk factors for 2009 pandemic influenza A (H1N1)-related hospitalization and death among racial/ethnic groups in New Mexico. Am J Public Health. 2011;101(9):1776–84. doi: 10.2105/AJPH.2011.300223
10. Mexico G de. Comunicado Tecnico Diario COVID-19- Reporte 29 de marzo [Internet]. 2020. Disponible en: https://coronavirus.gob.mx/noticias/
11. Instituto nacional de Salud C. COVID 19 Colombia-Reporte 30 de marzo [Internet]. 2020. Disponible en: https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx
12. Ministerio de Salud y Protección Social – Colombia. Encuesta Nacional de la Situación Nutricional ENSIN 2015 [Internet]. 2017. Disponible en: https://www.minsalud.gov.co/Paginas/Gobierno-presenta-Encuesta-Nacional-de-Situación-Nutricional-de-Colombia-ENSIN-2015.aspx
13. Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, et al. Cytokine release syndrome. J Immunother Cancer. 2018;6(1):56. doi: 10.1186/s40425-018-0343-9
14. Liu E, Marin D, Banerjee P, MacApinlac HA, Thompson P, Basar R, et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N Engl J Med. 2020;382(6):545–53. doi: 10.1056/NEJMoa1910607
15. Wang W, He J, Lie puyi, Huang liyan, Wu S, lin yongping, et al. The definition and risks of cytokine release syndrome-like in 11 COVID-19-infected pneumonia critically ill patients: disease characteristics and retrospective analysis. medRxiv. 2020. doi: https://doi.org/10.1101/2020.02.26.20026989.
16. Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunologic features in severe and moderate forms of Coronavirus Disease 2019. J Clin Invest. 2020;pii: 137244. doi: 10.1172/JCI137244
17. Rakotoarivelo V, Variya B, Langlois MF, Ramanathan S. Chemokines in human obesity. Cytokine [Internet]. 2020;127:154953. Available from: https://doi.org/10.1016/j.cyto.2019.154953
18. Aasheim ET, Hofsø D, Hjelmesœth J, Birkeland KI, Bøhmer T. Vitamin status in morbidly obese patients: A cross-sectional study. Am J Clin Nutr. 2008;87(2):362–9. doi: 10.1093/ajcn/87.2.362
19. Molnár D, Decsi T, Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes. 2004;28(10):1197–202. oi: 10.1038/sj.ijo.0802719
20. Ozata M, Mergen M, Oktenli C, Aydin A, Sanisoglu SY, Bolu E, et al. Increased oxidative stress and hypozincemia in male obesity. Clin Biochem. 2002;35(8):627–31. doi: 10.1016/s0009-9120(02)00363-6
21. Arnaud J, Bertrais S, Roussel AM, Arnault N, Ruffieux D, Favier A, et al. Serum selenium determinants in French adults: the SU.VI.M.AX study. Br J Nutr. 2006;95(2):313–20. doi: 10.1079/bjn20051528
22. Ferrante AW. Obesity-induced inflammation: A metabolic dialogue in the language of inflammation. J Intern Med. 2007;262(4):408–14. doi: 10.1111/j.1365-2796.2007.01852.x
23. Hotamisligil GS. Molecular mechanisms of insulin resistance and the role of the adipocyte. Int J Obes. 2000;24(Suppl. 4):S23–7. doi: 10.1038/sj.ijo.0801497
24. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M, et al. T-lymphocyte infiltration in visceral adipose tissue: A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol. 2008;28(7):1304–10. doi: 10.1161/ATVBAHA.108.165100
25. O’Rourke RW, Kay T, Scholz MH, Diggs B, Jobe BA, Lewinsohn DM, et al. Alterations in T-cell subset frequency in peripheral blood in obesity. Obes Surg. 2005;15(10):1463–8. doi: 10.1381/096089205774859308
26. Talbot HK, Coleman LA, Crimin K, Zhu Y, Rock MT, Meece J, et al. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine. 2012;30(26):3937–43. doi: 10.1016/j.vaccine.2012.03.071
27. Pi-Sunyer FX. Medical hazards of obesity. Ann Intern Med. 1993;119(7 Pt 2):655–60. doi: 10.7326/0003-4819-119-7_part_2-199310011-00006
28. Dietz W, Santos-Burgoa C. Obesity and its Implications for COVID-19 Mortality. Obesity (Silver Spring) [Internet]. 2020; Available from: http://www.ncbi.nlm.nih.gov/pubmed/32237206